AAPS Open

Table 4 IC₅₀ of different formulations against HepG2 cells for different incubation time

From: PEGylated magnetic nanographene oxide for targeted delivery of arsenic trioxide and sec-o-glucosylhamaudol in tumor treatment with improved dual-drugs synergistic effect

Time	Nanodrugs	IC₅₀(µg/mL)
24 h	PEG@MGO@SOG	87.41 ± 1.84
	PEG@MGO@ATO	51.87 ± 4.73
	PEG@MGO@ATO + SOG	27.07 ± 0.86
48 h	PEG@MGO@SOG	78.89 ± 2.55
	PEG@MGO@ATO	41.69 ± 2.22
	PEG@MGO@ATO + SOG	21.91 ± 1.78
72 h	PEG@MGO@SOG	68.99 ± 1.78
	PEG@MGO@ATO	30.89 ± 0.66
	PEG@MGO@ATO + SOG	15.62 ± 0.84

Back to article page